
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
PharmAust Limited is a biotechnology business based in Australia. PharmAust shares (PAA) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. PharmAust has a trailing 12-month revenue of around $4.1 million..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.057 - $0.25 |
---|---|
50-day moving average | $0.1072 |
200-day moving average | $0.1427 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.007 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$0.105 on 2021-01-25
1 week (2021-01-18) | 7.14% |
---|---|
1 month (2020-12-24) | -4.55% |
3 months (2020-10-23) | -19.23% |
6 months (2020-07-24) | -44.74% |
1 year (2020-01-24) | 9.37% |
---|---|
2 years (2019-01-25) | 182.26% |
3 years (2018-01-25) | 70.18% |
5 years (2016-01-22) | 14.50% |
Revenue TTM | $4.1 million |
---|---|
Gross profit TTM | $3.9 million |
Return on assets TTM | -8.06% |
Return on equity TTM | -17.04% |
Profit margin | -33.06% |
Book value | 0.028 |
Market capitalisation | $31.7 million |
TTM: trailing 12 months
We're not expecting PharmAust to pay a dividend over the next 12 months.
PharmAust 's shares were split on a 1:20 basis on 30 October 2015. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PharmAust shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for PharmAust shares which in turn could have impacted PharmAust 's share price.
Over the last 12 months, PharmAust 's shares have ranged in value from as little as $0.057 up to $0.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while PharmAust 's is 0.7043. This would suggest that PharmAust 's shares are less volatile than average (for this exchange).
PharmAust Limited, a clinical-stage company, develops targeted cancer therapeutics for human and animal healthcare. The company develops drug discovery intellectual property for the treatment of various cancers in humans and animals. Its lead candidate is Monepantel, which are in Phase II clinical trials for the treatment of cancer. The company also provides highly specialized medicinal and synthetic chemistry services on a contract basis to clients to the drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.
From the best overall face moisturiser for dry skin to the best body moisturiser, hand moisturiser and tinted moisturiser for dry skin, these are the best 7 moisturisers for dry skin you can buy in Australia right now.
From the best RC plane for beginners to the top model for aerial photography, these are the six best RC planes in Australia right now.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.